MedPath

High Doses Vitamin C and Tissular Repair in Surgical Patients

Not Applicable
Completed
Conditions
Tissue Damage
Registration Number
NCT04896359
Lead Sponsor
Universidad San Francisco de Quito
Brief Summary

This is a prospective, randomize, double-blind, and placebo-controlled study to evaluate in patients with clinical criteria for any of the following open surgical procedure: (1) cesarean section; (2) aesthetic surgery like abdominoplasty; (3) orthopedic surgery; and (4) abdominal open surgery \[excluding laparoscopic procedures\] will be invited to receive either a high dose of vitamin C (12.5 g) three times (48 h pre-surgery, immediately before surgery and 48 h post-surgery) or its placebo, to evaluate the tissue repair process using an international validated instrument named Patient and Observer Scar Assessment Scale.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Older than 18 years.
  • Susceptible for any of the following surgical procedures: (1) cesarean section; (2) aesthetic abdominal plastic surgery; (3) orthopedic prosthetic replacement surgery
  • Voluntary consent to participate
Exclusion Criteria
  • Known allergy to the vitamin C
  • Known problems with wounds healing
  • Kidney disease (including lithiasis) or gout

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Evaluation of linear scarsthird assessment, three months after surgery

Patient and Observer Scar Assessment Scale (it evaluates in a 0 to 10 scale: vascularity, pigmentation, thickness, relief, pliability and surface area)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital de los Valles

🇪🇨

Quito, Pichincha, Ecuador

Hospital de los Valles
🇪🇨Quito, Pichincha, Ecuador

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.